SMAD4 and colorectal carcinoma: SMAD4 mutations have also been shown to impact Wnt signaling activity through a SMAD4 R361 hotspot mutation, which alters Wnt/β-catenin pathways and contributes to the evasion of growth suppressors in CRC cells [442].